Arthur Gomtsyan

3.3k total citations · 1 hit paper
36 papers, 2.1k citations indexed

About

Arthur Gomtsyan is a scholar working on Organic Chemistry, Sensory Systems and Physiology. According to data from OpenAlex, Arthur Gomtsyan has authored 36 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Organic Chemistry, 14 papers in Sensory Systems and 11 papers in Physiology. Recurrent topics in Arthur Gomtsyan's work include Ion Channels and Receptors (14 papers), Pain Mechanisms and Treatments (10 papers) and Asymmetric Synthesis and Catalysis (7 papers). Arthur Gomtsyan is often cited by papers focused on Ion Channels and Receptors (14 papers), Pain Mechanisms and Treatments (10 papers) and Asymmetric Synthesis and Catalysis (7 papers). Arthur Gomtsyan collaborates with scholars based in United States, United Kingdom and Canada. Arthur Gomtsyan's co-authors include Stephen Hanessian, Michael F. Jarvis, Prisca Honoré, Connie R. Faltynek, James P. Sullivan, Heath A. McDonald, Chih‐Hung Lee, Kennan C. Marsh, Daniele Andreotti and Chengmin Zhong and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Neuroscience and Journal of Neurophysiology.

In The Last Decade

Arthur Gomtsyan

36 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Heterocycles in drugs and drug discovery

2012 483 citations Arthur Gomtsyan Chemistry of Heterocyclic Compounds profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arthur Gomtsyan United States	25	975	631	555	548	223	36	2.1k
Delia Preti Italy	37	1.7k 1.7×	691 1.1×	441 0.8×	1.5k 2.7×	442 2.0×	110	4.2k
Christopher Walpole Canada	17	209 0.2×	841 1.3×	553 1.0×	584 1.1×	477 2.1×	29	1.6k
Vigilio Ballabeni Italy	26	641 0.7×	98 0.2×	174 0.3×	690 1.3×	223 1.0×	89	2.1k
Matthew A. J. Duncton United States	21	1.2k 1.2×	325 0.5×	87 0.2×	436 0.8×	89 0.4×	49	1.8k
J. Guy Breitenbucher United States	26	663 0.7×	169 0.3×	210 0.4×	833 1.5×	322 1.4×	50	2.1k
A. Scott Hinman Canada	15	363 0.4×	1.1k 1.8×	322 0.6×	583 1.1×	509 2.3×	37	2.5k
Scott L. Dax United States	19	493 0.5×	222 0.4×	160 0.3×	450 0.8×	245 1.1×	50	1.1k
Geoffrey Stemp United Kingdom	23	852 0.9×	98 0.2×	122 0.2×	850 1.6×	561 2.5×	62	1.8k
Péter Mátyus Hungary	28	1.4k 1.4×	48 0.1×	212 0.4×	1.3k 2.3×	397 1.8×	184	2.9k
Jacek Sapa Poland	22	492 0.5×	46 0.1×	168 0.3×	547 1.0×	334 1.5×	119	1.7k

Countries citing papers authored by Arthur Gomtsyan

Since Specialization

Citations

This map shows the geographic impact of Arthur Gomtsyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur Gomtsyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur Gomtsyan more than expected).

Fields of papers citing papers by Arthur Gomtsyan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arthur Gomtsyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur Gomtsyan. The network helps show where Arthur Gomtsyan may publish in the future.

Co-authorship network of co-authors of Arthur Gomtsyan

This figure shows the co-authorship network connecting the top 25 collaborators of Arthur Gomtsyan. A scholar is included among the top collaborators of Arthur Gomtsyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arthur Gomtsyan. Arthur Gomtsyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gomtsyan, Arthur, Heath A. McDonald, Robert G. Schmidt, et al.. (2015). TRPV1 ligands with hyperthermic, hypothermic and no temperature effects in rats. Temperature. 2(2). 297–301. 21 indexed citations

Gomtsyan, Arthur. (2012). Heterocycles in drugs and drug discovery. Chemistry of Heterocyclic Compounds. 48(1). 7–10. 483 indexed citations breakdown →

Schmidt, Robert G., Erol K. Bayburt, Steven P. Latshaw, et al.. (2011). Chroman and tetrahydroquinoline ureas as potent TRPV1 antagonists. Bioorganic & Medicinal Chemistry Letters. 21(5). 1338–1341. 35 indexed citations

Perner, Richard J., John R. Koenig, Stanley DiDomenico, et al.. (2010). Synthesis and biological evaluation of 5-substituted and 4,5-disubstituted-2-arylamino oxazole TRPV1 antagonists. Bioorganic & Medicinal Chemistry. 18(13). 4821–4829. 31 indexed citations

Joshi, S. K., Prisca Honoré, Gricelda Hernandez, et al.. (2008). Additive Antinociceptive Effects of the Selective Nav1.8 Blocker A-803467 and Selective TRPV1 Antagonists in Rat Inflammatory and Neuropathic Pain Models. Journal of Pain. 10(3). 306–315. 40 indexed citations

Surowy, Carol S., Torben R. Neelands, Bruce R. Bianchi, et al.. (2008). (R)-(5-tert-Butyl-2,3-dihydro-1 H-inden-1-yl)-3-(1 H-indazol-4-yl)-urea (ABT-102) Blocks Polymodal Activation of Transient Receptor Potential Vanilloid 1 Receptors in Vitro and Heat-Evoked Firing of Spinal Dorsal Horn Neurons in Vivo. Journal of Pharmacology and Experimental Therapeutics. 326(3). 879–888. 38 indexed citations

Gomtsyan, Arthur, Erol K. Bayburt, Ryan G. Keddy, et al.. (2007). α-Methylation at benzylic fragment of N-aryl-N′-benzyl ureas provides TRPV1 antagonists with better pharmacokinetic properties and higher efficacy in inflammatory pain model. Bioorganic & Medicinal Chemistry Letters. 17(14). 3894–3899. 26 indexed citations

Bianchi, Bruce R., Rachid El Kouhen, Torben R. Neelands, et al.. (2007). [3H]A-778317 [1-((R)-5-tert-Butyl-indan-1-yl)-3-isoquinolin-5-yl-urea]: a Novel, Stereoselective, High-Affinity Antagonist Is a Useful Radioligand for the Human Transient Receptor Potential Vanilloid-1 (TRPV1) Receptor. Journal of Pharmacology and Experimental Therapeutics. 323(1). 285–293. 12 indexed citations

Matulenko, Mark A., Ernest S. Paight, Robin R. Frey, et al.. (2006). 4-Amino-5-aryl-6-arylethynylpyrimidines: Structure–activity relationships of non-nucleoside adenosine kinase inhibitors. Bioorganic & Medicinal Chemistry. 15(4). 1586–1605. 25 indexed citations

10.

Muchmore, Steven W., Richard A. Smith, Andrew O. Stewart, et al.. (2006). Crystal Structures of Human Adenosine Kinase Inhibitor Complexes Reveal Two Distinct Binding Modes. Journal of Medicinal Chemistry. 49(23). 6726–6731. 23 indexed citations

11.

Cui, Minghua, Prisca Honoré, Chengmin Zhong, et al.. (2006). TRPV1 Receptors in the CNS Play a Key Role in Broad-Spectrum Analgesia of TRPV1 Antagonists. Journal of Neuroscience. 26(37). 9385–9393. 252 indexed citations

12.

Honoré, Prisca, Carol T. Wismer, Joe Mikusa, et al.. (2005). A-425619 [1-Isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a Novel Transient Receptor Potential Type V1 Receptor Antagonist, Relieves Pathophysiological Pain Associated with Inflammation and Tissue Injury in Rats. Journal of Pharmacology and Experimental Therapeutics. 314(1). 410–421. 216 indexed citations

13.

Kouhen, Rachid El, Carol S. Surowy, Bruce R. Bianchi, et al.. (2005). A-425619 [1-Isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a Novel and Selective Transient Receptor Potential Type V1 Receptor Antagonist, Blocks Channel Activation by Vanilloids, Heat, and Acid. Journal of Pharmacology and Experimental Therapeutics. 314(1). 400–409. 90 indexed citations

14.

Gomtsyan, Arthur, Stanley DiDomenico, Chih‐Hung Lee, et al.. (2004). Synthesis and biological evaluation of pteridine and pyrazolopyrimidine based adenosine kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(16). 4165–4168. 28 indexed citations

15.

Gomtsyan, Arthur & Chih‐Hung Lee. (2004). Nonnucleoside Inhibitors of Adenosine Kinase. Current Pharmaceutical Design. 10(10). 1093–1103. 11 indexed citations

16.

Gfesser, Gregory A., Erol K. Bayburt, Marlon Cowart, et al.. (2003). Synthesis and structure-activity relationships of 5-heteroatom-substituted pyridopyrimidines as adenosine kinase inhibitors. European Journal of Medicinal Chemistry. 38(3). 245–252. 31 indexed citations

17.

Coveney, Peter V., et al.. (2000). Novel Approaches to Cross-linking High Molecular Weight Polysaccharides: Application to Guar-based Hydraulic Fracturing Fluids. Molecular Simulation. 25(5). 265–299. 12 indexed citations

18.

Gomtsyan, Arthur. (1999). Direct Synthesis of β-Aminoketones from Amides via Novel Sequential Nucleophilic Substitution/Michael Reaction. Organic Letters. 2(1). 11–13. 33 indexed citations

19.

Hanessian, Stephen, Daniele Andreotti, & Arthur Gomtsyan. (1996). Asymmetric Synthesis of Enantiomerically Pure and Diversely Functionalized Cyclopropanes J. Am. Chem. Soc. 1995, 117, 10393−10394. Journal of the American Chemical Society. 118(10). 2537–2537. 3 indexed citations

20.

Hanessian, Stephen & Arthur Gomtsyan. (1994). Highly stereocontrolled sequential asymmetric Michael addition reactions with cinnamate esters - generation of three and four contiguous stereogenic centers on seven-carbon acyclic motifs. Tetrahedron Letters. 35(41). 7509–7512. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact